New Developments in the Use of Atypical Antipsychotics in the Treatment of Bipolar Disorder: a Systematic Review of Recent Randomized Controlled Trials.

Current Psychiatry Reports
Kamyar KeramatianLakshmi N Yatham

Abstract

Atypical antipsychotics are increasingly used in the treatment of bipolar disorder (BD). This systematic review provides an overview of recently published randomized controlled trials (RCTs) on the efficacy and safety of atypical antipsychotics in BD. Several studies supported efficacy of quetiapine monotherapy in acute bipolar I (BDI) and bipolar II (BDII) depression. Moreover, quetiapine adjunctive therapy showed superior efficacy to placebo in treatment-resistant bipolar depression. Cariprazine 1.5 mg was effective in treating bipolar I depression. Aripiprazole 400 mg IM once monthly was effective in preventing manic episodes with minimal metabolic effects. In youth with BD, lurasidone was effective and well-tolerated for acute depression while asenapine showed efficacy in treating acute manic and mixed episodes. Recently published RCTs generally support the efficacy of atypical antipsychotics in different phases of BD. Future studies should focus on understudied populations including pediatric BD and geriatric BD and BDII, as well as a focus on cognitive functioning and quality of life measures.

References

Nov 22, 1997·Journal of Psychiatric Research·J C RobbR T Joffe
Mar 10, 2001·Psychiatric Services : a Journal of the American Psychiatric Association·G M MacQueen, L T Young
Apr 20, 2007·Journal of Affective Disorders·Julie GarnhamMartin Alda
Apr 25, 2007·The Journal of Pediatrics·Gabriele S LeverichDavid Luckenbaugh
Oct 19, 2007·Acta Psychiatrica Scandinavica. Supplementum·I J TorresL N Yatham
Oct 27, 2007·The Journal of Clinical Psychiatry·Paul E KeckUNKNOWN Aripiprazole Study Group
Jan 22, 2008·Journal of Clinical Psychopharmacology·Michael E ThaseRandall Owen
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Jul 30, 2010·The Journal of Clinical Psychiatry·Robert M PostWillem A Nolen
Mar 9, 2011·Archives of General Psychiatry·Kathleen R MerikangasZahari Zarkov
Feb 28, 2015·Journal of the American Academy of Child and Adolescent Psychiatry·Holland C DetkeRoland W Usher
Apr 18, 2015·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Keltie C McdonaldScott B Patten
Mar 4, 2017·The British Journal of Psychiatry : the Journal of Mental Science·Michael BerkSue M Cotton
Jul 12, 2017·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Joseph R CalabreseAntony Loebel
Jul 15, 2017·Child and Adolescent Psychiatry and Mental Health·Daniel J WalkerHolland C Detke
Sep 9, 2017·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Marina GarrigaEduard Vieta
Nov 17, 2017·The Australian and New Zealand Journal of Psychiatry·Marco Antonio CaldieraroAndrew A Nierenberg
Nov 28, 2017·Journal of the American Academy of Child and Adolescent Psychiatry·Melissa P DelBelloAntony Loebel
Nov 28, 2017·Journal of Affective Disorders·Joseph R CalabreseWilliam H Carson
Jan 13, 2018·Depression and Anxiety·Marco Antonio CaldieraroAndrew A Nierenberg
Feb 24, 2019·Journal of Affective Disorders·Mirjana ValdesLakshmi N Yatham
Mar 9, 2019·The American Journal of Psychiatry·Willie EarleyLakshmi N Yatham
Jun 18, 2019·Journal of Clinical Psychopharmacology·Vivek MahajanSamir Kumar Praharaj
Aug 30, 2019·BMJ : British Medical Journal·Jonathan A C SterneJulian P T Higgins
Jul 3, 2020·Journal of Child and Adolescent Psychopharmacology·Joshua V StreicherMelissa P DelBello

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.